I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …
Category Archive: metastatic cancer cells
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Tags: NDNano
Aug 30
Nanoparticles that act as an “ON and OFF” switch to improve the safety and effectiveness of CAR-T cancer therapy
AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Harper Cancer Research Institute, Immunotherapy, metastatic cancer cells
by Prakash
Always thankful for the internal support from Notre Dame Research #notredameresearch for supporting high risk-high gain projects such as mine. Here’s hoping that my faculty research support program initiation grant (FRSP-IG) #FRSP will pave the way for safer, more accessible CAR-T therapies and better quality of life for patients. https://research.nd.edu/news/developing-an-on-and-off-switch-for-breast-cancer-treatment/ The biggest bottle neck in Chimeric …
Tags: NDNano
Jul 02
Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters
AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells
by Prakash
Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Tags: NDNano
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Notice of Early Expiration of Notices of Funding Opportunities Related to the Simplified Review Framework for NIH Research Grant Applications May 15, 2025Notice NOT-OD-25-113 from the NIH Guide for Grants and Contracts
- Notice of Correction of Key Dates to PAR-25-235 "Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)" May 15, 2025Notice NOT-LM-25-003 from the NIH Guide for Grants and Contracts
- Request for Information (RFI): Benchmarks for Artificial Intelligence in Cancer Research and Care May 14, 2025Notice NOT-CA-25-037 from the NIH Guide for Grants and Contracts
- Request for Information (RFI): Inviting Comments on the Future of the National Library of Medicine Biomedical and Data Science Extramural Research Programs May 14, 2025Notice NOT-LM-25-002 from the NIH Guide for Grants and Contracts
- Notice of Correction to Application Due Dates for RFA-OD-24-011 "NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)" May 14, 2025Notice NOT-OD-25-089 from the NIH Guide for Grants and Contracts
- Notice of Change to Advisory Council Review for PAR-25-131 May 14, 2025Notice NOT-LM-25-001 from the NIH Guide for Grants and Contracts
- Notice of Change: NINDS Participation in PAR-22-213 "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)" May 14, 2025Notice NOT-NS-25-021 from the NIH Guide for Grants and Contracts
- Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)" May 14, 2025Notice NOT-DA-24-062 from the NIH Guide for Grants and Contracts
- Notice of Correction to RFA-HL-26-014 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) May 14, 2025Notice NOT-HL-25-006 from the NIH Guide for Grants and Contracts
- Notice of Change to PAR-25-139 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) May 14, 2025Notice NOT-CA-25-045 from the NIH Guide for Grants and Contracts
Recent Comments